For Patients and Caregivers:

About the GO-ID Genotyping Study to Identify People Who Have POMC or LepR Deficiency Obesity

We invite you to participate in the GO-ID Genotyping study, which is looking at samples of people’s genes to determine if they may have obesity from POMC (pro-opiomelanocortin) or LepR (leptin receptor) deficiency—two rare but important types of genetic, early-onset obesity.

This genetic testing may help you better understand the cause of obesity in you or your child. In addition, patients who test positive for POMC or LepR deficiency may be eligible to participate in future studies focused on understanding and treating childhood obesity.

If you or a member of your family has the following characteristics, they can apply to participate in the GO-ID Genotyping study:

  • At least 2 years old
  • Have been severely obese since you were very young (before age 6)
  • Have constant severe hunger, also known as hyperphagia

Click here for more information about participating in the GO-ID Genotyping study.

If you have any questions, please do not hesitate to contact us:
E |

This program is supported by Rhythm, a Boston-based biopharmaceutical company developing the MC4R peptide agonist, setmelanotide (RM-493), for obesity caused by genetic deficiencies in the MC4 pathway.
Back to Top